Cover Image
市場調查報告書

B細胞淋巴瘤:全球臨床實驗檢討

B-Cell Lymphomas Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 230760
出版日期 內容資訊 英文 193 Pages
訂單完成後即時交付
價格
Back to Top
B細胞淋巴瘤:全球臨床實驗檢討 B-Cell Lymphomas Global Clinical Trials Review, H1, 2014
出版日期: 2014年02月19日 內容資訊: 英文 193 Pages
簡介

本報告提供B細胞淋巴瘤相關的臨床研究最新趨勢分析,以疾病概要為首,提供G7各國·E7各國的臨床實驗狀況,彙整各地區、各階段的進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊,為您概述為以下內容。

目錄

簡介

  • B細胞淋巴瘤
  • 該報告內容架構

各地區的臨床實驗

  • 各國臨床實驗數量
    • 亞太地區臨床實驗數量的前五名國家
    • 歐洲的臨床實驗數量的前五名國家
    • 北美臨床實驗數量的前幾名國家
    • 中東·非洲的臨床實驗數量的前五名國家
    • 中南美的臨床實驗數量的前五名國家

G7各國的臨床實驗

G7各國的臨床實驗:各進展狀況

E7各國的臨床實驗

E7各國的臨床實驗:各進展狀況

不同階段臨床實驗情形

  • 進行中的臨床實驗:不同階段

各階段臨床實驗情形

一定期間所採用的實驗對象

有潛力的贊助商

有潛力的藥劑

臨床實驗簡介

  • 前幾名企業臨床實驗概要
    • F. Hoffmann-La Roche Ltd.
    • Celgene Corporation
    • 武田藥品工業
    • GlaxoSmithKline plc
    • Novartis AG
    • Biogen Idec Inc.
    • Pfizer Inc.
    • Pharmacyclics, Inc.
    • Amgen Inc.
    • Janssen Global Services, LLC
  • 前幾名大學·研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • Fred Hutchinson Cancer Research Center
    • The University of Texas M. D. Anderson Cancer Center
    • Memorial Sloan Kettering Cancer Center Southwest Oncology Group
    • Groupe d'Etudes de Lymphomes de L'Adulte
    • Mayo Clinic
    • City of Hope National Medical Center

5個有代表性的臨床實驗簡介

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC1993CTIDB

GlobalData's clinical trial report, "B-Cell Lymphomas Global Clinical Trials Review, H1, 2014" provides data on the B-Cell Lymphomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on B-Cell Lymphomas . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating B-Cell Lymphomas . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • B-Cell Lymphomas
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of B-Cell Lymphomas to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of B-Cell Lymphomas to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of B-Cell Lymphomas
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in B-Cell Lymphomas Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on B-Cell Lymphomas
    • Jan 29, 2014: Cancer Research UK launches trial of new lymphoma treatment
    • Dec 10, 2013: Senesco's Drug Candidate SNS01-T Selectively Kills Cancer Cells and Not Healthy Cells in Disease Models
    • Dec 06, 2013: Rhizen Pharmaceuticals announces initiation of a "First in Human" Phase-1 trial of RP6530, a dual PI3K delta/gamma inhibitor, in patients with hematological malignancies
    • Dec 06, 2013: TG Therapeutics Launches Combination Clinical Trial of TG-1101 and Ibrutinib in Patients With Select B-Cell Malignancies
    • Jun 19, 2013: Senesco Announces Results Of Cohort 2 Of Its SNS01-T Phase Ib/IIa Trial
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Celgene Corporation
      • Clinical Trial Overview of Celgene Corporation
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Biogen Idec Inc.
      • Clinical Trial Overview of Biogen Idec Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Pharmacyclics, Inc.
      • Clinical Trial Overview of Pharmacyclics, Inc.
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Janssen Global Services, LLC
      • Clinical Trial Overview of Janssen Global Services, LLC
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Fred Hutchinson Cancer Research Center
      • Clinical Trial Overview of Fred Hutchinson Cancer Research Center
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Southwest Oncology Group
      • Clinical Trial Overview of Southwest Oncology Group
      • Groupe d'Etudes de Lymphomes de L'Adulte
      • Clinical Trial Overview of Groupe d'Etudes de Lymphomes de L'Adulte
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • City of Hope National Medical Center
      • Clinical Trial Overview of City of Hope National Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • B-Cell Lymphomas Therapeutics, Global, Clinical Trials by Region, 2014*
  • B-Cell Lymphomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • B-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of B-Cell Lymphomas to Oncology Clinical Trials, G7 Countries (%), 2014*
  • B-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • B-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of B-Cell Lymphomas to Oncology Clinical Trials, E7 Countries (%), 2014*
  • B-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • B-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • B-Cell Lymphomas Therapeutics, Global, Clinical Trials by Phase, 2014*
  • B-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • B-Cell Lymphomas Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • B-Cell Lymphomas Therapeutics, Global, Suspended Clinical Trials, 2014*
  • B-Cell Lymphomas Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • B-Cell Lymphomas Therapeutics, Global, Terminated Clinical Trials, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe d'Etudes de Lymphomes de L'Adulte, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2014*

List of Figures

  • B-Cell Lymphomas Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • B-Cell Lymphomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • B-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of B-Cell Lymphomas to Oncology Clinical Trials, G7 Countries (%), 2014*
  • B-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • B-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of B-Cell Lymphomas to Oncology Clinical Trials, E7 Countries (%), 2014*
  • B-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • B-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • B-Cell Lymphomas Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • B-Cell Lymphomas Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • B-Cell Lymphomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top